Response to preoperative chemotherapy in patients undergoing resection of pulmonary metastasis from soft tissue sarcoma – a predictor of outcome?

References

• Brennan MF, Singer S, Maki RG, O’Sullivan B. Soft tissue sarcoma. In Cancer principles and practice of oncology. 7th ed. DeVita Jr VT, Hellman S, Rosenberg SA, editors. Philadelphia: Lippincott Williams and Wilkins; 2005. p 1581–637.
   Google Scholar
• Gadd MA, Casper ES, Woodruff JM, McCormack PM, Brennan MF. Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma. Ann Surg 1993;218:705–12.
   PubMed Web of Science ®Google Scholar
• Casson AG, Putnam JB, Natarajan G, Johnston DA, Mountain C, McMurtrey M, et al. Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma. Cancer 1992;69:662–8.
   PubMed Web of Science ®Google Scholar
• Billingsley KG, Burt ME, Jara E, Ginsberg RJ, Woodruff JM, Leung DH, et al. Pulmonary metastases from soft tissue sarcoma: Analysis of patterns of diseases and postmetastasis survival. Ann Surg 1999;229:602–10.
   PubMed Web of Science ®Google Scholar
• Kager L, Zoubek A, Potschger U, Kastner U, Flege S, Kempf-Bielack B, et al. Primary metastatic osteosarcoma: Presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 2003;21:2011–8.
   PubMed Web of Science ®Google Scholar
• Alvegard TA, Saeter G. The role of pulmonary metastasectomy for soft tissue sarcoma. Acta Orthop Scand Suppl 1997;273:145–7.
   PubMedGoogle Scholar
• Choong PF, Pritchard DJ, Rock MG, Sim FH, Frassica FJ. Survival after pulmonary metastasectomy in soft tissue sarcoma. Prognostic factors in 214 patients. Acta Orthop Scand 1995;66:561–8.
   PubMed Web of Science ®Google Scholar
• Canter RJ, Qin LX, Downey RJ, Brennan MF, Singer S, Maki RG. Perioperative chemotherapy in patients undergoing pulmonary resection for metastatic soft-tissue sarcoma of the extremity: A retrospective analysis. Cancer 2007;110: 2050–60.
   PubMed Web of Science ®Google Scholar
• van Geel AN, Blum RH, Alvegaard T, Baker LH. NCT00002764. EORTC-62933-SSG: Metastasectomy and chemotherapy for lung metastases from soft tissue sarcoma: A randomized phase III study (an intergroup study with the Scandinavian Sarcoma Group). 1997. Available from: http://www.clinicaltrial.gov
   Google Scholar
• Wiklund T, Saeter G, Strander H, Alvegard T, Blomqvist C. The outcome of advanced soft tissue sarcoma patients with complete tumour regression after either chemotherapy alone or chemotherapy plus surgery. The Scandinavian Sarcoma Group experience.Eur J Cancer 1997;33:357–61.
   PubMed Web of Science ®Google Scholar
• Blay JY, van Glabbeke M, Verweij J, van Oosterom AT, Le CA, Oosterhuis JW, et al. Advanced soft-tissue sarcoma: A disease that is potentially curable for a subset of patients treated with chemotherapy. Eur J Cancer 2003; 39:64–9.
   PubMed Web of Science ®Google Scholar
• Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207–14.
   PubMed Web of Science ®Google Scholar
• Huvos A. Pathologic assessment of preoperative (neoadjuvant) chemotherapy. In: Bone tumors: Diagnosis, treatment and prognosis. 2nd ed. Philadelphia: W.B.Saunders Co.; 1991. p 122–8.
   Google Scholar
• Casper ES, Gaynor JJ, Harrison LB, Panicek DM, Hajdu SI, Brennan MF. Preoperative and postoperative adjuvant combination chemotherapy for adults with high grade soft tissue sarcoma. Cancer 1994;73:1644–51.
   PubMed Web of Science ®Google Scholar
• Bacci G, Mercuri M, Longhi A, Ferrari S, Bertoni F, Versari M, et al. Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution. Eur J Cancer 2005;41:2079–85.
   PubMed Web of Science ®Google Scholar
• Lucas DR, Kshirsagar MP, Biermann JS, Hamre MR, Thomas DG, Schuetze SM, et al. Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: Clinicopathological correlation. Oncologist 2008;13:451–8.
   PubMed Web of Science ®Google Scholar
• Schmidt RA, Conrad EU III, Collins C, Rabinovitch P, Finney A. Measurement and prediction of the short-term response of soft tissue sarcomas to chemotherapy. Cancer 1993;72:2593–601.
   PubMed Web of Science ®Google Scholar
• Menendez LR, Ahlmann ER, Savage K, Cluck M, Fedenko AN. Tumor necrosis has no prognostic value in neoadjuvant chemotherapy for soft tissue sarcoma. Clin Orthop Relat Res 2007;455:219–24.
   PubMed Web of Science ®Google Scholar
• Eilber FC, Rosen G, Eckardt J, Forscher C, Nelson SD, Selch M, et al. Treatment-induced pathologic necrosis: A predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas. J Clin Oncol 2001;19:3203–9.
   PubMed Web of Science ®Google Scholar
• Pezzi CM, Pollock RE, Evans HL, Lorigan JG, Pezzi TA, Benjamin RS, et al. Preoperative chemotherapy for soft-tissue sarcomas of the extremities. Ann Surg 1990; 211:476–81.
   PubMed Web of Science ®Google Scholar
• Tierney JF, Stewart LA, Parmar MK. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: Meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet 1997;350:1647–54.
   PubMed Web of Science ®Google Scholar
• Blackmon SH, Shah N, Roth JA, Correa AM, Vaporciyan AA, Rice DC, et al. Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival. Ann Thorac Surg 2009;88:877–84.
   PubMed Web of Science ®Google Scholar
• Nachman J, Simon MA, Dean L, Shermeta D, Dawson P, Vogelzang NJ. Disparate histologic responses in simultaneously resected primary and metastatic osteosarcoma following intravenous neoadjuvant chemotherapy. J Clin Oncol 1987;5:1185–90.
   PubMed Web of Science ®Google Scholar
• Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.J Natl Cancer Inst 2000;92: 205–16.
   PubMed Web of Science ®Google Scholar